With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Read More
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Read More
© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin